These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 32632231)

  • 21. Move quickly to detach: Strain rate-dependent myosin detachment and cardiac relaxation.
    Chung CS
    J Gen Physiol; 2020 Apr; 152(4):. PubMed ID: 32197272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.
    Teerlink JR; Felker GM; McMurray JJ; Solomon SD; Adams KF; Cleland JG; Ezekowitz JA; Goudev A; Macdonald P; Metra M; Mitrovic V; Ponikowski P; Serpytis P; Spinar J; Tomcsányi J; Vandekerckhove HJ; Voors AA; Monsalvo ML; Johnston J; Malik FI; Honarpour N;
    Lancet; 2016 Dec; 388(10062):2895-2903. PubMed ID: 27914656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CK-1827452, a sarcomere-directed cardiac myosin activator for acute and chronic heart disease.
    Solaro RJ
    IDrugs; 2009 Apr; 12(4):243-51. PubMed ID: 19350469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.
    Broughton KM; Li J; Sarmah E; Warren CM; Lin YH; Henze MP; Sanchez-Freire V; Solaro RJ; Russell B
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H107-17. PubMed ID: 27199119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular mechanisms underlying deoxy-ADP.Pi activation of pre-powerstroke myosin.
    Nowakowski SG; Regnier M; Daggett V
    Protein Sci; 2017 Apr; 26(4):749-762. PubMed ID: 28097776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac myosin activation: will theory and practice coincide?
    Dickstein K
    Lancet; 2011 Aug; 378(9792):639-41. PubMed ID: 21856465
    [No Abstract]   [Full Text] [Related]  

  • 27. Exploration of diphenylalkyloxadiazoles as novel cardiac myosin activator.
    Manickam M; Boggu PR; Pillaiyar T; Sharma N; Jalani HB; Venkateswararao E; Jung SH
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2369-2374. PubMed ID: 29937058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single cardiac ventricular myosins are autonomous motors.
    Wang Y; Yuan CC; Kazmierczak K; Szczesna-Cordary D; Burghardt TP
    Open Biol; 2018 Apr; 8(4):. PubMed ID: 29669825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
    Massengill MT; Ashraf HM; Chowdhury RR; Chrzanowski SM; Kar J; Warren SA; Walter GA; Zeng H; Kang BH; Anderson RH; Moss RL; Kasahara H
    Cardiovasc Res; 2016 Jul; 111(1):34-43. PubMed ID: 27025239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to Letter Regarding Article, "Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity".
    Bakkehaug JP; Kildal AB; Engstad ET; Boardman N; Næsheim T; Rønning L; Aasum E; Larsen TS; Myrmel T; How OJ
    Circ Heart Fail; 2015 Nov; 8(6):1142. PubMed ID: 26738203
    [No Abstract]   [Full Text] [Related]  

  • 31. A trinucleotide repeat combination polymorphism in the cardiac alpha myosin heavy chain (MYH6) gene.
    van den Berg MH; Meijer H; Geraedts JP
    Hum Genet; 1995 Jun; 95(6):723-4. PubMed ID: 7789965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetic-pharmacodynamic modeling of omecamtiv mecarbil, a cardiac myosin activator, in healthy volunteers and patients with stable heart failure.
    Vu T; Ma P; Xiao JJ; Wang YM; Malik FI; Chow AT
    J Clin Pharmacol; 2015 Nov; 55(11):1236-47. PubMed ID: 25951506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter by Teerlink et al Regarding Article, "Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Resting Myosin ATPase Activity".
    Teerlink JR; Malik FI; Kass DA
    Circ Heart Fail; 2015 Nov; 8(6):1141. PubMed ID: 26578671
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac myosin isoforms from different species have unique enzymatic and mechanical properties.
    Malmqvist UP; Aronshtam A; Lowey S
    Biochemistry; 2004 Nov; 43(47):15058-65. PubMed ID: 15554713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac Myosin Activators in Systolic Heart Failure: More Friend than Foe?
    Moin DS; Sackheim J; Hamo CE; Butler J
    Curr Cardiol Rep; 2016 Oct; 18(10):100. PubMed ID: 27568794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myosin light chain 2 into the mainstream of cardiac development and contractility.
    Moss RL; Fitzsimons DP
    Circ Res; 2006 Aug; 99(3):225-7. PubMed ID: 16888245
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel slow-skeletal myosin (MYH7) mutation in the original myosin storage myopathy kindred.
    Dye DE; Azzarelli B; Goebel HH; Laing NG
    Neuromuscul Disord; 2006 Jun; 16(6):357-60. PubMed ID: 16684601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new approach to inotropic therapy in the treatment of heart failure: cardiac myosin activators in treatment of HF.
    Garg V; Frishman WH
    Cardiol Rev; 2013; 21(3):155-9. PubMed ID: 23018669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease.
    Sheikh F; Lyon RC; Chen J
    Gene; 2015 Sep; 569(1):14-20. PubMed ID: 26074085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The isoforms of α-actin and myosin affect the Ca
    Shchepkin DV; Nikitina LV; Bershitsky SY; Kopylova GV
    Biochem Biophys Res Commun; 2017 Aug; 490(2):324-329. PubMed ID: 28623140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.